June 24, 2022
Beat of the Week
(Honorable Mention)
AP: FDA skipped most baby formula plant inspections in 2020
turned seemingly mundane testimony of a legislative hearing into a timely scoop, breaking the news that the Food and Drug Administration had skipped nearly all its inspections of baby formula plants during the first year of COVID, likely contributing to the severe shortage of formula in the U.S. and raising questions about what the federal government could have done to prevent it.Using information he gleaned from Capitol Hill testimony by the three top baby formula manufacturers, Washington-based health writer Perrone identified the companies’ plants in the FDA’s online database and discovered the agency hadn’t inspected Abbott’s plant — responsible for a recall of formula that exacerbated the nationwide shortage — for two years between 2019 and 2021. In fact, the FDA later acknowledged only three of the nation’s 23 formula plants were inspected in the first year of the pandemic.Read more